Daewoong Pharmaceutical Launches Global Talent Recruitment in Indonesia... "Securing R&D Capabilities"

Global Talent Recruitment Planned for the Second Half of This Year

Daewoong Pharmaceutical has embarked on securing outstanding talent to leap forward as a global big pharma.

Daewoong Pharmaceutical Global Talent Class 1.
[Photo by Daewoong Pharmaceutical]

Daewoong Pharmaceutical announced on the 3rd that it has hired 19 global talents in the pharmaceutical and bio-related fields from Indonesia as the first batch to strengthen its global research and development (R&D) capabilities.

Daewoong Pharmaceutical selected experts in pharmacy, biology, chemistry, and engineering from Indonesia. The first batch of global talents, composed of specialists including medical professionals and students from major local universities such as the University of Indonesia and Bandung Institute of Technology, will start working in the quality department (QA/QC) at Daewoong Pharmaceutical’s Osong Smart Factory. Through the Career Development Program (CDP), a career development HR system, the company will also provide opportunities for them to expand their roles as experts in production, research, development, and global business.

Employees with excellent research capabilities can develop their careers as R&D experts in research and development by participating in projects at the research institute that study prescription, processes, and quality testing methods for chemical new drugs, generics, improved new drugs, bio new drugs, and biosimilars. Additionally, based on their research results, they will have opportunities to become Regulatory Affairs (RA) experts who obtain drug approvals, handle changes, and conduct evaluations, as well as to promote Daewoong Group’s overseas business.

Daewoong Pharmaceutical explained that its global recruitment goes beyond simple hiring and is operated in an 'All-Care' format for outstanding talents. To help employees smoothly adapt to life in Korea, the company plans to provide support such as housing, Korean life guidance, telecommunications device activation, financial transaction guidance, and welcome kits.

Muhammad Uril Absor, who is scheduled to work as a member of the QC team at the Osong factory, said, "I am pleased to take the first step to grow as a global pharmaceutical industry expert at Daewoong Pharmaceutical, a leading Korean pharmaceutical company. Since they provide full support in various aspects such as housing, language education, and life guidance to help me focus on my work, I will strive to repay this with results."

Daewoong Pharmaceutical expects that this global talent recruitment will be a turning point for the company to leap beyond Korea and become a global big pharma. The second batch of global talents, selected through a local recruitment process in February, consists of about 60 people, tripling the size of the first batch. Those currently undergoing internship evaluations in Indonesia will be assigned to Korean production facilities after passing the final evaluation. Daewoong Pharmaceutical plans to continue large-scale recruitment activities in the second half of this year to select more global talents from Indonesia.

Seungho Jeon, CEO of Daewoong Pharmaceutical, said, "The recruitment of the first batch of global talents is a milestone showing that Daewoong Pharmaceutical continues to grow in global markets including Indonesia. Daewoong Pharmaceutical plans to continuously expand local research institutes and production facilities in Indonesia to nurture talent."

Daewoong Pharmaceutical has selected Indonesia as a Southeast Asian hub country and is pursuing business diversification such as local production, technology transfer, and research institute establishment to grow into the top pharmaceutical company locally.

This content was produced with the assistance of AI translation services.